All In Biotech

Drug Trial Radar · NCT00856973

Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia

A Randomized, Placebo Controlled, Double Blind, Fixed Dose Study of the Efficacy and Safety of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia

Last checked: Nov 20, 2026Latest source record: Jun 17, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 486 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

486

Actual

Start

May 2009

Primary completion

Jul 2011

Study completion Jul 2011

Sponsor

Lead sponsor
Sumitomo Pharma America, Inc.Industry
Sponsor type
Industry
First posted
Mar 6, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 6 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A multi center, randomized study to evaluate the efficacy and safety of eszopiclone compared to placebo in children (6-11 years of age, inclusive) and adolescents (12-17 years of age, inclusive) with attention deficit/hyperactivity disorder (ADHD) associated insomnia.

Conditions

  • Insomnia
  • Attention Deficit Hyperactivity Disorder

Interventions

  • eszopicloneDrug

    1 mg eszopiclone for 6-11 years, 2 mg for 12-17 years

  • eszopicloneDrug

    2 mg eszopiclone for 6-11 years, 3 mg eszopiclone for 12-17 years

  • PlaceboDrug

    1 tablet per day for 12 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline to the End of the Double- Blind Treatment Period (Week 12) in Polysomnography (PSG) Defined Latency to Persistent Sleep (LPS).Time frame: Baseline (Day 0) to Week 12

Locations

73 sites in 1 country. Site status is shown where the registry gives one.

  • Sleep Disorders Center of Alabama

    Birmingham, Alabama

  • Dothan Behavioral Medicine Clinic

    Dothan, Alabama

  • Metropolitan Neuro Behavioral Institute

    Chandler, Arizona

  • PsyPharma Clinical Research

    Phoenix, Arizona

  • REM Medical Clinical Research

    Tucson, Arizona

  • Paul E. Wylie

    Little Rock, Arkansas

  • AV Institute, Inc.

    Carson, California

  • Clinical Innovations, Inc.

    Costa Mesa, California

  • Avastra Clinical Trials

    Fountain Valley, California

  • Behavioral Research Specialists, LLC

    Glendale, California

  • Pacific Institute for Medical Research Inc

    Los Angeles, California

  • Excell Research, Inc.

    Oceanside, California

  • North County Clinical Research (NCCR)

    Oceanside, California

  • Pacific Clinical Research Medical Group

    Orange, California

  • SDS Clinical Trials

    Orange, California

  • California Clinical Trials Medical Group

    Paramount, California

  • Clinical Innovations, Inc.

    Riverside, California

  • Artemis Institute for Clinical Research

    San Diego, California

  • Clinical Innovations, Inc.

    San Diego, California

  • Neuropsychiatric Research Center of Orange County

    Santa Ana, California

  • Clinical Innovations, Inc.

    Santa Ana, California

  • Elite Clinical Trials

    Wildomar, California

  • Delta Waves, INC

    Colorado Springs, Colorado

  • Sarkis Clinical Trials

    Gainesville, Florida

  • MD Clinical

    Hallandale, Florida

  • Florida Clinical Research Center LLC

    Maitland, Florida

  • Florida Institute for Clinical Research, LLC

    Orlando, Florida

  • SomnoMedics, LLC

    Tampa, Florida

  • Pediatric Epilepsy and Neurology Specialists

    Tampa, Florida

  • Neuro Trials Research, Inc.

    Atlanta, Georgia

  • Sleep Disorders Center of Georgia

    Atlanta, Georgia

  • Mountain West Clinical Trials

    Eagle, Idaho

  • Alexian Brothers Center for Psychiatric Research

    Hoffman Estates, Illinois

  • AMR Baber Research Inc.

    Naperville, Illinois

  • American Medical Research, Inc.

    Oak Brook, Illinois

  • Davis Clinic

    Indianapolis, Indiana

  • Goldpoint Clinical Research

    Indianapolis, Indiana

  • Psychiatric Associates

    Overland Park, Kansas

  • Pedia Research LLC

    Owensboro, Kentucky

  • Louisiana Research Associates, Inc.

    New Orleans, Louisiana

Showing 40 of 73 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.